SOTERA HEALTH COMPANY Asset Retirement Obligation, Accretion Expense
SOTERA HEALTH COMPANY (SHC) reported Asset Retirement Obligation, Accretion Expense of $1.31 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetRetirementObligationAccretionExpense · last filed 2026-08-06
- SOTERA HEALTH COMPANY asset retirement obligation, accretion expense for the quarter ending 2026-06-30 was $633.00K, a 12.63% increase year-over-year.
- SOTERA HEALTH COMPANY asset retirement obligation, accretion expense for the quarter ending 2026-03-31 was $673.00K, a 17.25% increase year-over-year.
- SOTERA HEALTH COMPANY asset retirement obligation, accretion expense for the quarter ending 2025-12-31 was $584.00K, a 19.23% decline year-over-year.
- SOTERA HEALTH COMPANY asset retirement obligation, accretion expense for the quarter ending 2025-09-30 was $601.00K, a 5.65% decline year-over-year.
- SOTERA HEALTH COMPANY asset retirement obligation, accretion expense for fiscal 2025 was $2.32M, a 12.02% decline from fiscal 2024.
- SOTERA HEALTH COMPANY asset retirement obligation, accretion expense for fiscal 2024 was $2.64M, a 9.32% increase from fiscal 2023.
- SOTERA HEALTH COMPANY asset retirement obligation, accretion expense for fiscal 2023 was $2.41M, a 9.98% increase from fiscal 2022.
- SOTERA HEALTH COMPANY asset retirement obligation, accretion expense for fiscal 2022 was $2.19M, a 2.58% decline from fiscal 2021.
| Period end | Asset Retirement Obligation, Accretion Expense 3 month | Asset Retirement Obligation, Accretion Expense 6 month | Asset Retirement Obligation, Accretion Expense 9 month | Asset Retirement Obligation, Accretion Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $633.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.31M 10-Q · filed 2026-08-06 | $1.89M derived: sum of 3 quarters · filed 2026-08-06 | $2.49M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $673.00K 10-Q · filed 2026-05-05 | $1.26M derived: sum of 2 quarters · filed 2026-05-05 | $1.86M derived: sum of 3 quarters · filed 2026-05-05 | $2.42M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $584.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.19M derived: sum of 2 quarters · filed 2026-02-24 | $1.75M derived: sum of 3 quarters · filed 2026-08-06 | $2.32M 10-K · filed 2026-02-24 |
| 2025-09-30 | $601.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.16M derived: sum of 2 quarters · filed 2026-08-06 | $1.74M 10-Q · filed 2025-11-04 | $2.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $562.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.14M 10-Q · filed 2026-08-06 | $1.86M derived: sum of 3 quarters · filed 2026-08-06 | $2.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $574.00K 10-Q · filed 2026-05-05 | $1.30M derived: sum of 2 quarters · filed 2026-05-05 | $1.93M derived: sum of 3 quarters · filed 2026-05-05 | $2.57M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $723.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.36M derived: sum of 2 quarters · filed 2026-02-24 | $2.00M derived: sum of 3 quarters · filed 2026-02-24 | $2.64M 10-K · filed 2026-02-24 |
| 2024-09-30 | $637.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.27M derived: sum of 2 quarters · filed 2025-11-04 | $1.92M 10-Q · filed 2025-11-04 | $2.65M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $636.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $1.28M 10-Q · filed 2025-08-08 | $2.01M derived: sum of 3 quarters · filed 2026-02-24 | $2.56M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $642.00K 10-Q · filed 2025-05-01 | $1.37M derived: sum of 2 quarters · filed 2026-02-24 | $1.93M derived: sum of 3 quarters · filed 2026-02-24 | $2.48M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $730.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.29M derived: sum of 2 quarters · filed 2026-02-24 | $1.84M derived: sum of 3 quarters · filed 2026-02-24 | $2.41M 10-K · filed 2026-02-24 |
| 2023-09-30 | $556.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $1.11M derived: sum of 2 quarters · filed 2024-11-05 | $1.68M 10-Q · filed 2024-11-05 | $2.23M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $555.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $1.13M 10-Q · filed 2024-08-05 | $1.68M derived: sum of 3 quarters · filed 2025-02-27 | $2.20M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $572.00K 10-Q · filed 2024-05-02 | $1.12M derived: sum of 2 quarters · filed 2025-02-27 | $1.65M derived: sum of 3 quarters · filed 2025-02-27 | $2.25M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $549.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.08M derived: sum of 2 quarters · filed 2025-02-27 | $1.67M derived: sum of 3 quarters · filed 2025-02-27 | $2.19M 10-K · filed 2025-02-27 |
| 2022-09-30 | $527.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $1.13M derived: sum of 2 quarters · filed 2023-11-01 | $1.65M 10-Q · filed 2023-11-01 | $2.15M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $598.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $1.12M 10-Q · filed 2023-08-03 | $1.62M derived: sum of 3 quarters · filed 2024-02-27 | $2.22M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $520.00K 10-Q · filed 2023-05-03 | $1.02M derived: sum of 2 quarters · filed 2024-02-27 | $1.62M derived: sum of 3 quarters · filed 2024-02-27 | $2.22M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $501.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.10M derived: sum of 2 quarters · filed 2024-02-27 | $1.70M derived: sum of 3 quarters · filed 2024-02-27 | $2.25M 10-K · filed 2024-02-27 |
| 2021-09-30 | $598.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $1.20M derived: sum of 2 quarters · filed 2022-11-02 | $1.75M 10-Q · filed 2022-11-02 | $2.25M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $602.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.15M 10-Q · filed 2022-08-04 | $1.65M derived: sum of 3 quarters · filed 2023-02-28 | $2.18M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $551.00K 10-Q · filed 2022-05-05 | $1.05M derived: sum of 2 quarters · filed 2023-02-28 | $1.57M derived: sum of 3 quarters · filed 2023-02-28 | $2.08M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $495.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.02M derived: sum of 2 quarters · filed 2023-02-28 | $1.53M derived: sum of 3 quarters · filed 2023-02-28 | $2.00M 10-K · filed 2023-02-28 |
| 2020-09-30 | $528.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $1.03M derived: sum of 2 quarters · filed 2021-11-10 | $1.50M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $503.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $974.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $471.00K 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $2.05M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |